Genetic and Molecular Basis of Longevity
The summary for the Genetic and Molecular Basis of Longevity grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Genetic and Molecular Basis of Longevity: The National Institute on Aging (NIA) invites applications for new and competing renewal applications for research project grants (R01) to support basic research on the genetic and molecular basis of longevity. The goals of the "Genetic and Molecular Basis of Longevity" Request for Applications (RFA) are to identify and functionally characterize genes that play a role in determining and modulating longevity and health span and determine the molecular mechanism(s) of action of these Longevity Assurance Genes (LAGs). Longevity Assurance Genes are operationally defined as genes that: determine, modulate or promote longevity and extend health span; maintain cell, tissue and/or organ function; and regulate and/or maintain organismal homeostasis. A multidisciplinary approach to the study of the complex traits of aging and longevity, including the application of genetic, molecular and biochemical approaches and techniques, has significantly accelerated research progress toward an in depth understanding of the genes, proteins, and biochemical pathways that modulate and play significant functional roles in aging and longevity in both invertebrate and mammalian species. Candidate LAGs that fit one or more of the above classifications have been identified in several invertebrates (Saccharomyces cerevisiae, Drosophila melanogaster, Caenorhabditis elegans), mice and humans. The continued development and application of multidisciplinary scientific approaches to the elucidation of the genetic and molecular basis of aging and longevity is strongly encouraged in applications submitted in response to this RFA.
| Federal Grant Title: | Genetic and Molecular Basis of Longevity |
| Federal Agency Name: | National Institutes of Health |
| Grant Categories: | Health |
| Type of Opportunity: | Discretionary |
| Funding Opportunity Number: | RFA-AG-04-003 |
| Type of Funding: | Grant |
| CFDA Numbers: | 93.866 |
| CFDA Descriptions: | Aging Research |
| Current Application Deadline: | No deadline provided |
| Original Application Deadline: | Oct 22, 2003 |
| Posted Date: | Aug 07, 2003 |
| Creation Date: | Nov 21, 2003 |
| Archive Date: | Nov 21, 2003 |
| Total Program Funding: | |
| Maximum Federal Grant Award: | |
| Minimum Federal Grant Award: | |
| Expected Number of Awards: | |
| Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- State governments County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- Webmaster, NIH, Webmaster, Phone not available, Fax not available, Email [email protected] [email protected] Webmaster, NIH
- Similar Government Grants
- • Artificial Intelligence and Technology Collaboratory (P30 Clinical Trial Optional)
- • Artificial Intelligence and Technology Collaboratory Coordinating Center (U24 Clinical Tri...
- • Claude D. Pepper Older Americans Independence Centers (P30 Clinical Trial Optional)
- • NIA Expanding Research in AD/ADRD (ERA) Summer Research Education Program (R25 Independent...
- • NIA Expanding Research in AD/ADRD (ERA) Postbaccalaureate Research Education Program (R25 ...
- • Technological Enhancements and Archiving for Surveys of the Elderly: SBIR (R43/44) Initiat...
- • Technological Enhancements and Archiving for Surveys of the Elderly: STTR (R41/42) Initiat...
- • Technology and Aging: NIA Small Business Technology Transfer Program Initiative (STTR [R41...
- More Grants from the National Institutes of Health
- • Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeu...
- • Early-Stage Development of Informatics Technologies for Cancer Research and Management (U0...
- • Advanced Development of Informatics Technologies for Cancer Research and Management (U24 C...
- • Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Cli...
- • NCI Community Oncology Research Program (NCORP) Academic Community Sites (UG1 Clinical Tri...
